This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Apr 20;152(8):JC4-7.

doi: 10.7326/0003-4819-152-8-201004200-02007.

Dabigatran was noninferior to warfarin for preventing recurrent venous thromboembolism

Esteban Gandara¹

Affiliations

PMID: 20404376
DOI: 10.7326/0003-4819-152-8-201004200-02007

Comment

Dabigatran was noninferior to warfarin for preventing recurrent venous thromboembolism

Esteban Gandara. Ann Intern Med. 2010.

. 2010 Apr 20;152(8):JC4-7.

doi: 10.7326/0003-4819-152-8-201004200-02007.

Author

Esteban Gandara¹

Affiliation

¹ University of Ottawa, Ontario, Canada.

PMID: 20404376
DOI: 10.7326/0003-4819-152-8-201004200-02007

No abstract available

PubMed Disclaimer

Comment on

Dabigatran versus warfarin in the treatment of acute venous thromboembolism.
Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ; RE-COVER Study Group. Schulman S, et al. N Engl J Med. 2009 Dec 10;361(24):2342-52. doi: 10.1056/NEJMoa0906598. N Engl J Med. 2009. PMID: 19966341 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon